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Myocardial Infarc.on in Women versus Men
Anna Day, BSN, RN
OWerbein University, Westerville, Ohio

Introduc(on
As a future advance practice nurse (APN),
it is important to recognize the symptoms
of myocardial infarction (MI) and provide
prompt treatment to patients to reduce
morbidity and mortality. The worldwide
leading cause of death is cardiovascular
disease (CVD). In 2008, coronary heart
disease (CHD) was the cause of 7.3 million
deaths, while cerebrovascular disease was
responsible for 6.2 million deaths. Since
cardiovascular disease is the leading cause
of death for women, it is imperative for the
medical community to identify risk factors
and seek an increased awareness of gender
differences (Worrall-Carter et al., 2011).
After myocardial infarction, 23% of women
over the age of 40 will die in the Wirst
subsequent year. After age 70, this Wigure
rises to 32%. It has also been determined
that younger women have a higher
propensity to die in the 2 years after MI
versus older women. (DeVon et al., 2011).

As a student and future APN, it is of
the highest importance to learn and
recognize varying different
presenting symptoms of myocardial
infarction, and to initiate prompt
treatment to prevent further
irreversible damage to the patient’s
heart and consequently other body
systems (Van Berlo & Molkentin,
2014). Time is of the most critical
importance due to the cardiac
muscle’s inability to regenerate.
Initiating a speciWic algorithm to
treat the patient presenting with
symptoms of MI in a timely manner
could mean the difference between
life and death (Kalman et al., 2013)

Pathophysiology and its Signiﬁcance

It has been esWmated that over 42 million
women in the United States have been
diagnosed with cardiovascular disease (CVD).
In 2008, about 17.3 million people worldwide
died from CVD (DeVon, Saban, & Garre^,
2011; Almond, Salisbury & Ziebland, 2012).
The study has shown that aler age 40,
approximately 23% of women die in the ﬁrst
year following the myocardial infarcWon (MI),
and 32% aler age 70. This study also has
showed the deaths rates to be three Wmes
higher for women younger then 50 years
compared to men ((DeVon at el., 2011). Over
the years, the mortality rates from CVD have
been decreasing in women as well as men,
however, the mortality rate is decreasing less
vigorously in women (Kalman at el., 2013).
The decline in deaths in females nearly 22%
between 1996 and 2006 has been contributed
in the improvement in awareness of risk,
primary and secondary prevenWon, lifestyle
changes, early deﬁbrillaWon, and advanced
treatments (DeVon at el., 2011).
Over the years, coronary heart disease (CHD)
has been described as the presence of
atheroscleroWc lesions in the epicardial
coronary arteries which result in narrowing or
occlusion of the vessel lumen. However, the
recent study does not support this
pathophysiology of CHD in women, staWng
that heart disease is primarily a ma^er of
epicardial stenosis (Edwards, 2012, p.575).
Research studies have shown that women
who undergo coronary angioplasty for
evaluaWon of chest pain very olen have no
evidence of obstrucWve coronary disease,
which puts them into a category of the
presence of “clear arteries” and low cardiac
risk.

The same study showed that about 50% of
women with heart disease show normal
coronary arteries, compared to 17% in men
(Edwards, 2012, p.575).
Coronary microvascular disease (CVD) is
consequence of damage to the arterial walls.
This disorder is more prevalent in women
than men, and it aﬀects about 3 million
women in the United States. Microvascular
disease develops as result of diﬀuse plaque
deposit, spasms of coronary arteries, and/or
damage to the vessel wall. This small vessel
disease reduces coronary blood ﬂow and
eventually leads to ischemic disease
(Edwards, 2012, p.575).
The pathophysiology of heart disease in
women is impacted by endothelial funcWon.
Myocardial ischemia can be the result of
endothelial dysfuncWon even if obstrucWve
lesions are not present. Endothelial
dysfuncWon is a term used to describe a
change in the blood vessel lining resulWng
from a decrease in nitric oxide (vasodilator
and vascular smooth muscle relaxant) which
impedes blood ﬂow and weakens
vasodilaWon. Endothelial dysfuncWon appears
to be the result of the presence of plaque
which sWmulates vessel restructuring
(Edwards, 2012, p.575).
In men, a MI usually begins with the sudden
rupture of cholesterol ﬁlled plaque in a
coronary artery, which eventually
precipitates a blood clot. In women, plaque is
more likely to erode into the vessel wall
rather than to burst (DeVon at el., 2011).

Unique Signs and Symptoms Women versus
Men
Many studies have proven that men and
women can experience the signs and
symptoms of MI
diﬀerently. In general, symptoms of MI are
more dramaWc in men and more subtle in
women (Almond at el., 2012; DeVon at el.,
2011; Edwards, 2012; Mackay at el., 2011;
Poon at el., 2012; Van Berlo & MolkenWn,
2014).
!

!

Unlike men, women frequently
experience atypical symptoms suggesWve
of MI, which in many cases delay them
from seeking help (Edwards, 2012).

Atypical symptoms accompany MI in
Women are more likely to report nausea
and shortness of breath, but less likely
report sweaWng compared with men
(could be related to symptoms of
peri-menopausal symptoms)
(Edwards, 2012).

!

The main diﬀerence idenWﬁed between
women and men include that women are
less aware of risks, less likely to
experience chest pain and have higher
incidence of prodromal symptoms. As a
result of that the evidence suggest that
women may experience delays in triage\
and be treated diﬀerently from men.
Research shows that the average delay
ranged from 1.8 to 7.2 hours in women
compared with 1.4 to 3.5 hour is in men
(Almond at el., 2012).
Atypical symptoms accompany MI in
women include faWgue (59%), shortness
of breath (59%), weakness (47%), nausea
(44%), sweaWng/hot sensaWon (43%), and
dizziness (42%) (Edwards, 2012).

!

!

!
!
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Pathophysiological analysis of CAD
has shown that gender based
considerations are decisively
signiWicant in determining the
existence of MI in women. The
Women’s Ischemic Syndrome
Evaluation (WISE) has
demonstrated that CAD in women
can often beconvincingly associated
with endothelial dysfunction
(Mieres & Bonow, 2016).

!

The diﬀerence even in the pathology
between the two genders is crucial to
understand for healthcare
professionals. The knowledge and
data gathered from the researchers
should be Wlized and implemented in
the pracWce and with the ﬁrst contact
with the paWent.

!

As many researchers are indicaWng, it
is also important to promote a
healthy lifestyle and focus modiﬁable
CVD risk factors such as:
hypertension, hyperlipidemia,
smoking, diabetes, physical acWvity,
obesity, diet and alcohol consumpWon
(Worrall-Carter at el., 2011). All
these factors are very inﬂuenWal in
the disease process and the
outcome.

!

With a thorough awareness of the
pathophysiological process, advance
pracWce nurses can be instrumental in
reducing morbidity and mortality
associated with myocardial infarcWon.
AddiWonally, close scruWny must be
applied to potenWal female risk
indicators such as hormonal changes
aler menopause and endothelial
funcWon.

Women are more likely to report nausea
and shortness of breath, but less likely
report sweaWng compared with men
(could be related to symptoms of perimenopausal symptoms) Edwards, 2012).

https://myheartsisters.org/2015/09/20/most-common-heart-attack-signs
!

http://cs.mcgill.ca/~rwest/wikispeedia/wpcd/wp/m/Myocardial_infarction.htm

!

Implica(ons

Women are 2-3 Wmes likely than men to
report pain in the lel arm, hand, lel
scapula and neck. Because of these mild
symptoms, women’s heart a^acks are
olen misdiagnosed (Worrall-Carter at
el., 2011).
Hormonal changes aler menopause play
a role in heart disease process in women.
Decreased estrogen causes lipid
dysfuncWons and signiﬁcantly increases
the incidence of MI
Insuline resistance and high triglycerides
appear to be more harmful to women’s
hearts.
Some studies have revealed that 19.8%
of women and 13.7% of men
experienced prodromal symptoms 90
days prior to the acute event. Those
symptoms included pain, anxiety,
faWgue, breathlessness, nausea, jaw
pain, and pain in the shoulder blade and
upper back (Poon at el., 2012)

.

Conclusion

According to the study, it has been proven
that 50% of MI experienced by women is
undiagnosed and unrecognized, in
comparison to a 33% staWsWc for men
(Worrall-Carter at el., 2014).
As many researchers have suggested,
women experience MI diﬀerently than
men. Stereotypically, MI has been
associated with crushing central chest pain,
which is typical for men, but is not a
common symptom for women. Because of
these atypical symptoms women very
frequently are being misdiagnosed when
presented with acute coronary syndrome,
which eventually leads to myocardial
infarcWon (Mackay at el., 2011).
As the study suggests, gender diﬀerence is
signiﬁcant when it comes to early
recogniWon of signs and symptoms of MI in
women and men. It is fundamental, as
healthcare workers, to be well aware of
these “silent” and atypical symptoms in
women in order to make an early
recogniWon and diagnosis of the disease.
There is a need for addiWonal educaWon
between healthcare workers and women
themselves about speciﬁc gender
diﬀerences when it comes to
heart disease.
Also, Van Berlo and MolkenWn (2014),
stated in their research that women are
underrepresented in cardiovascular disease
prevenWon clinical trials. Some acWon
should be taken, and more women should
be involved in prevenWve care, including
clinical trials. Risk factor modiﬁcaWons are
the major key in prevenWon of
cardiovascular disease. The focus should be
switched to risk factor idenWﬁcaWon and
awareness of sex diﬀerences. As healthcare
workers we should encourage more gender
speciﬁc clinical trials, advocate for women,
and help them get involved and parWcipate
in clinical trials to even be^er understand
the presentaWon and diﬀerences of the
symptoms between both genders.
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